Exact Mass: 715.3931412

Exact Mass Matches: 715.3931412

Found 117 metabolites which its exact mass value is equals to given mass value 715.3931412, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Saquinavir-NO

N-{4-[3-(tert-butyl-C-hydroxycarbonimidoyl)-decahydroisoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C38H49N7O7 (715.3693284000001)

9alpha,13alpha-diacetoxy-10beta-benzyloxy-5alpha-(3-dimethylamino-3-phenyl)-propionyloxy-11(15->1)abeotaxa-4(20),11-diene-15-ol

C42H53NO9 (715.3720128)

Leu-Gln-Gly-Ala-Ser-Leu-Lys

C31H57N9O10 (715.4228182)

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693284000001)

Phenalinolactone A

C38H53NO12 (715.3567578)

FQFFK

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693284000001)

PS(13:0/18:3(6Z,9Z,12Z))

1-tridecanoyl-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS(13:0/18:3(9Z,12Z,15Z))

1-tridecanoyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS(14:1(9Z)/17:2(9Z,12Z))

1-(9Z-tetradecenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS(17:2(9Z,12Z)/14:1(9Z))

1-(9Z,12Z-heptadecadienoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS(18:3(6Z,9Z,12Z)/13:0)

1-(6Z,9Z,12Z-octadecatrienoyl)-2-tridecanoyl-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS(18:3(9Z,12Z,15Z)/13:0)

1-(9Z,12Z,15Z-octadecatrienoyl)-2-tridecanoyl-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

PS 31:3

1-(9Z,12Z-heptadecadienoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

C37H66NO10P (715.4424106)

erbium tris(2,2,6,6-tetramethyl-3,5-heptanedionate)

C33H57ErO6 (715.3457972000001)

Boc-Gln-Arg-Arg-AMC

C32H49N11O8 (715.3765394000001)

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

C28H49N11O11 (715.3612844)

GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

2-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin

C28H57N7O14 (715.3963302)

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

C38H49N7O7 (715.3693284000001)

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

2-amino-3-[[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(7Z,10Z,13Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

C36H61NO13 (715.4142696)

(4Z,7Z,10Z,13Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]hexadeca-4,7,10,13-tetraenamide

C36H61NO13 (715.4142696)

(2S)-2-amino-3-[2,3-bis[[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy]propoxy-hydroxyphosphoryl]oxypropanoic acid

C38H54NO10P (715.3485154)

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4212822)

(2S)-2-amino-3-[hydroxy-[(2S)-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2S)-2-amino-3-[hydroxy-[(2S)-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2S)-2-amino-3-[[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4212822)

(2S)-2-amino-3-[[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C40H62NO8P (715.4212822)

(2S)-2-amino-3-[[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C40H62NO8P (715.4212822)

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2S)-2-amino-3-[[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C37H66NO10P (715.4424106)

neocasomorphin(1-)

C35H51N6O10 (715.3666486000001)

A peptide anion obtained from the deprotonation of the two carboxy groups, and protonation of the primary amino group of neocasomorphin. It is the major species at pH 7.3.